SGLT2 Inhibitors in the Post-Myocardial Infarction Population:

SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question

Listen now

Description

Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)? Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu

More Episodes

See all »

A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD

Are you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients? Credit available for this activity expires: 06/06/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000828?ecd=bdc_podcast_libsyn_mscpedu

Published 06/07/24

Keeping Current

Published 06/07/24

Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer Management

Are you up to date on the key clinical data on ADCs in breast cancer -- especially those that set the stage for upcoming data releases? Credit available for this activity expires: 5/31/2024 Earn Credit / Learning Objectives & Disclosures: ...

Published 05/31/24